Release Date: 29/11/12 11:58 Summary: Boardroom Radio Interview Price Sensitive: No Download Document 180.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%